ReviewFrontiers in neurology
Mapping neurodegeneration with diffusion MRI: biomarkers, mechanisms, and clinical translation.
Review in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Agitation, Alzheimer's disease, and autophagy: mechanistic insights into aging pathways, gut microbiome, and artificial intelligence.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurodegenerative diseases share convergent mechanisms involving microstructural degeneration, neuroinflammation, vascular dysfunction, and impaired brain fluid homeostasis. The neurovascular unit (NVU) represents a critical interface where these processes interact, integrating neuronal, glial, vascular, and perivascular components that regulate metabolism, immune surveillance, and waste clearance. This review examines advanced diffusion MRI as a noninvasive framework to investigate NVU-related pathology, with a specific focus on tissue microstructure, water dynamics, and perivascular spaces (PVS). We summarize diffusion MRI techniques ranging from conventional diffusion tensor imaging to multi-compartment and biophysical models that probe neurite architecture, extracellular free water, and perivascular transport. Across aging and major neurodegenerative disorders, diffusion-derived markers consistently reveal microstructural disorganization, extracellular fluid expansion, PVS enlargement, and glymphatic dysfunction. These alterations reflect coupled tissue-fluid pathology rather than isolated cellular damage. While advanced diffusion approaches provide increased sensitivity to early and subtle changes, they are influenced by acquisition quality, model assumptions, physiological confounders, and limited histopathological validation. Importantly, diffusion MRI metrics should be interpreted as complementary biomarkers that enhance, but do not replace, established diagnostic criteria and molecular biomarkers for specific neurodegenerative diseases. When integrated within multimodal and longitudinal frameworks, diffusion MRI offers valuable insights into NVU dysfunction, supporting early disease stratification, progression monitoring, and mechanistic understanding of neurodegeneration.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.